trending Market Intelligence /marketintelligence/en/news-insights/trending/4LD43xUEbCsZu-tyXqX6IA2 content esgSubNav
In This List

Rhinomed shares begin trading on OTCQB

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Rhinomed shares begin trading on OTCQB

Rhinomed Ltd. was approved for listing on the OTCQB Venture Market.

The Australian medical technology company is listed on the OTCQB under the RHNMF ticker symbol. The shares were approved to start trading Sept. 12.

Rhinomed is also trading on the Australian Stock Exchange under the RNO symbol.

Rhinomed's products include Turbine, a nasal dilator that assists in breathing during aerobic exercise, and Mute, a nasal technology that improves sleep quality.